Your trusted partner in advanced wound care solutions
Advancing Wound Care. Enhancing Lives.
Delivering innovative regenerative solutions, unmatched service, and exceptional value to support better outcomes for patients and providers.
RevivaMed Solutions is a distribution company for amniotic allografts and advanced wound-care products — expanding global access to innovative solutions for care providers, distributors and healthcare systems.
A focused wound-care portfolio
Personalized wound care solutions for clinical teams, providers, and distribution partners — organized into four product families.
Amniotic Membranes
5 productsHuman amniotic-membrane tissue allografts used as barriers and protective coverings for wounds and, for the ocular product, the ocular surface.
View productsAntimicrobial Matrices
2 productsFully synthetic antimicrobial matrices, including a version that releases a uniform unit-dose of lidocaine HCl.
View productsBioengineered Wound Products
1 productA biomaterial built around the healing process, combining a collagen derivative, Manuka honey and hydroxyapatite.
View productsAutologous Blood-Derived
1 productPoint-of-care products prepared from a small sample of the patient's own peripheral blood during a dressing session.
View productsResearch Peptides
39 productsGLP research peptides, single research peptides and multi-peptide blends, listed by vial strength.
View productsWho we serve
One portfolio, three kinds of partner — from a single clinic to a national system.
Care providers
Clinics and practices that need amniotic membrane allografts, antimicrobial matrices and point-of-care products they can order and apply without friction.
Distributors
Distribution partners who want a focused wound-care portfolio, clear product codes and consistent supply for their own territories.
Healthcare systems
Systems and group purchasing teams standardizing on a portfolio that spans amniotic coverings, antimicrobial technology and autologous options.
Backed by published evidence
Our products are supported by peer-reviewed studies on amniotic membrane allografts in hard-to-heal wounds — including diabetic foot ulcers.
Read the studies we share with providers, along with the research, clinical and quality infrastructure behind the portfolio.
Explore the evidenceContact us
Send an inquiry, email or call — we'll come back with product options and availability.

